Thailand Cold-Chain Pharma, Vaccine Deep Dive
Thai cold-chain pharma ~THB 18-25B. DHL Pharma, Kuehne+Nagel, Yusen, SCGJWD, DKSH, Zuellig. Ambient, refrigerated, frozen, ultra-cold mRNA-vaccine.
Key takeaways
- 1
- 2
Temperature mix: ambient-controlled 15-25Β°C ~, refrigerated 2-8Β°C ~, frozen -20-30Β°C ~, ultra-cold -70-80Β°C ~, cryo+specialty ~.
- 3
Operators: DHL Supply Chain Pharma, Kuehne+Nagel KN PharmaChain, Yusen, Nippon Express, SCGJWD, DKSH Healthcare, Zuellig Pharma, LF Logistics.
- 4
GPO state vaccine, biologics production, cold-chain integration; Thai FDA, GDP, WHO PQS, IATA CEIV regulate.
- 5
Drivers: COVID-19 vaccine, mRNA, biologics, insulin/GLP-1, clinical-trial, biosimilar, medical-tourism structural growth.
Executive summary
Thai cold-chain pharma, vaccine logistics market reaches ~ FY2024 covering temperature-controlled storage, transport, distribution, last-mile of pharmaceutical, vaccine, biologics, diagnostic, clinical-trial product. Categories by temperature: ambient-controlled (15-25Β°C) ~ of value covering most oral solid, liquid pharmaceutical products requiring controlled-room-temperature; refrigerated (2-8Β°C) ~ covering most vaccines, insulin, biologics, GLP-1, monoclonal antibody, protein therapy; frozen (-20Β°C to -30Β°C) ~ covering selective vaccine, biologic, sample; ultra-cold (-70Β°C to -80Β°C) ~ covering mRNA-vaccine (Pfizer-BioNTech, Moderna COVID), advanced biologics, cell therapy; cryo, specialty, clinical-trial ~ covering frozen tissue, cell-bank, research sample.[, , ]
Operators: DHL Supply Chain Pharma, DHL eCommerce Thailand (Deutsche Post DHL) β global leader in cold-chain pharma, ultra-cold mRNA-vaccine, dedicated facility, IATA CEIV certified. Kuehne+Nagel KN PharmaChain, KN PharmaCare β Swiss multinational global cold-chain pharma, vaccine integrated. Yusen Logistics Pharma, Nippon Express Pharma (Japanese NX Group, NYK Group) β Japanese auto-OEM-pharma adjacency, Thai-Japanese MNC, tier-2 cold-chain. SCGJWD Logistics (post-2023 SCG-JWD merger) β Thai-corporate cold-chain pharma, vaccine, biologics integrated; WHA Pharmaceutical industrial estate, warehouse-for-rent. DKSH Healthcare Thailand, LF Logistics, Zuellig Pharma, smaller specialty β Thai pharmaceutical distribution, cold-chain integration; serve multinational, Thai generic, GPO state.[, , , , , ]
GPO, multinational, drivers, regulation: GPO (Government Pharmaceutical Organization), GPO BioPharm Thai vaccine, biologics production, cold-chain integration; Thai-produced AstraZeneca COVID vaccine 2021-2022 leveraged GPO, Siam Bioscience, cold-chain backbone. Multinational pharma (Pfizer, Roche, Sanofi, Novartis, Novo Nordisk, Eli Lilly, Merck, GSK, AstraZeneca, J&J), Thai generic (GPO, Siam Pharmaceutical, LBS, Thai Otsuka) drive demand. Drivers: COVID-19 vaccine surge 2021-2023 transformative for Thai cold-chain capacity, ultra-cold expansion; post-COVID structural demand: mRNA-vaccine pipeline, biologics, insulin/GLP-1, clinical-trial, bio-similar, medical-tourism, private-hospital, retail-pharmacy growth. Regulation: Thai FDA, GDP (Good Distribution Practice), WHO PQS Performance Quality Safety, IATA CEIV Pharma air cargo, cold-chain integrity, temperature-mapping, audit, serialisation.[, , , , ]
Thai cold-chain pharma temperature mix (% of FY2024 value)
Ambient-controlled (15-25Β°C)
Share %
Product, use case
Most oral solid, liquid pharmaceutical; controlled-room-temperature
Refrigerated (2-8Β°C)
Share %
Product, use case
Most vaccines, insulin, biologics, GLP-1, mAb
Frozen (-20Β°C to -30Β°C)
Share %
Product, use case
Selective vaccine, biologic, sample
Ultra-cold (-70Β°C to -80Β°C)
Share %
6%
Product, use case
mRNA-vaccine (Pfizer-BioNTech, Moderna), advanced biologics, cell therapy
Cryo, specialty, clinical-trial
Share %
4%
Product, use case
Frozen tissue, cell-bank, research sample
| Temperature range | Share % | Product, use case |
|---|---|---|
| Ambient-controlled (15-25Β°C) | 46% | Most oral solid, liquid pharmaceutical; controlled-room-temperature |
| Refrigerated (2-8Β°C) | 32% | Most vaccines, insulin, biologics, GLP-1, mAb |
| Frozen (-20Β°C to -30Β°C) | 12% | Selective vaccine, biologic, sample |
| Ultra-cold (-70Β°C to -80Β°C) | 6% | mRNA-vaccine (Pfizer-BioNTech, Moderna), advanced biologics, cell therapy |
| Cryo, specialty, clinical-trial | 4% | Frozen tissue, cell-bank, research sample |
Unlock the full report
Need more than the web report? Ask for a scoped export or source appendix.
Every report keeps visible citations and source metadata. Terms.
Related reports
Thailand 3PL Warehouse, Last-Mile Deep Dive
Deep-dive into Thai 3PL, warehouse, last-mile market ~THB 250-300B FY2024 β ~4% of GDP logistics spend. Listed: SCGJWD Logistics (SET: SCGJWD post-2023 SCG-JWD merger), NCL International Logistics (SET: NCL), Demco. Foreign-parent: DHL Supply Chain, Yusen Logistics, Nippon Express, Kuehne+Nagel, DB Schenker, Damco, Geodis, DSV. Industrial-estate warehouse: WHA, Amata, FPT, Hemraj, Asia Industrial Estate, IEAT-managed. Last-mile parcel: Kerry Express, Flash Express, JNT Express, Ninja Van, Best Inc, ThailandPost, DHL eCommerce, LINE MAN. Cold-chain, pharma, e-commerce, cross-border ASEAN growing.
Open report β
Thailand Cold Chain Logistics Market Intelligence
Thailand cold-chain logistics sector generates approximately THB 45-50B in annual revenue serving food export (seafood, poultry, fruit), domestic food FMCG, pharma temperature-controlled distribution, and a rapidly growing e-grocery segment. SCGJWD Logistics anchors the listed side post-merger; NCL International serves reefer trade; CP Foods and Thai Union operate the largest captive cold chains. Report maps demand drivers, operator concentration, and infrastructure policy (BOI, EEC, PAT reefer capacity).
Open report β
Thailand Freight and Shipping Market Intelligence
Thailand freight, shipping, logistics market generates approximately USD 9.5B in FY2024 revenue (SCB EIC, Krungsri, KResearch cross-tabulated with MOT logistics master plan). Mode mix: road haulage 60% (deeply fragmented across 400k+ registered trucks with mid-tier private fleets and TIFFA-aggregated forwarders), ocean container 22% (Laem Chabang ~9M TEU as Thailand's primary deep-sea gateway, Bangkok Port ~1.4M TEU feeder), air cargo 8% (Suvarnabhumi, Don Mueang bellyhold and freighter), rail, cross-border 6% (SRT double-track upgrades, China-Thailand-Laos rail), cold-chain, specialty 4%. Listed operators anchor visible scale: Regional Container Lines (SET: RCL) intra-Asia container shipping, NCL International (SET: NCL) and SCGJWD (SET: SJWD) on integrated logistics, Kerry Express (SET: KEX) on parcel. Private leaders: Flash Express, J&T Express, Thailand Post, DHL Express, FedEx, Nippon Express, Yusen Logistics. Policy anchors: BOI Section 8 logistics, IBC incentives, MOT 10-year master plan targeting 12% logistics-cost-to-GDP, Customs Thai-NSW single window, EEC Laem Chabang Phase 3 PPP, China-Thailand HSR Phase 2.
Open report β
Thailand Logistics & Warehousing Market Intelligence
Thailand logistics cost ~13.2% of GDP (down from 14.1% 2019) per NESDC. Listed industrial estate, warehouse: WHA Corporation (SET: WHA, ~3M sqm stock), Amata Corporation (SET: AMATA, Chonburi-anchored), Frasers Property Thailand (SET: FPT, JV platform). Last-mile: Flash Express (private unicorn, 5,000+ distribution points), Kerry/SJWD (SET: SJWD post-2023 merger), Shopee Xpress, J&T Express, Thailand Post, Lazada Logistics. Laem Chabang Port 9M TEU 2024; AOT air cargo 1.3M tonnes; Thailand-China rail Phase 1 2027 target transformative. Land, Multimodal Transport Acts, EEC industrial policy, EV commercial-vehicle transition shape 2026-2028.
Open report β